In conclusion, we have shown in the present study that WMJ-S-001 exhibits anti-tumor effects, at least in part, via AMPK-p38MAPK-p53-survivin signaling cascade in HCT116 colorectal cancer cells. This evidence concerns the gene TP53 and neoplasm.